For patients with recurrent or refractory graft-versus-host disease (GVHD), the colony-stimulating factor 1 receptor ...

Findings from the phase 3 SIERRA study showed that Iomab-B was associated with a higher durable complete response rate vs ...

Committee for Medicinal Products for Human Use (CHMP) has recommended approving AstraZeneca’s Fasenra (benralizumab) to treat ...

The primary goals of the study are to evaluate the safety and overall response rate in patients who are given RLS-0071.

During the 131st SLSWCA meeting held under chairmanship of Chief Secretary Manoj Ahuja, the investment plans across various ...

During a Case-Based Roundtable® event,  Michael R. Bishop, MD, moderated a discussion on monitoring and treatment of chronic ...

Bhubaneswar: Odisha’s State Level Single Window Clearance Authority (SLSWCA) on Tuesday approved 31 projects worth around Rs ...

A rare cause of hereditary cognitive decline known as CSF1R-Related Disorder (CSF1R-RD) gets its name from mutations in the ...

If approved, AZN's Fasenra will be the second biologic approved in the European Union to treat eosinophilic granulomatosis ...

If you suffered losses exceeding $50,000 in Agenus between January 23, 2023 and July 17, 2024 and would like to discuss your ...

With FDA approval for imetelstat and solid financials, Geron shows great promise in MDS treatment. Read more on GERN stock ...

Multiple myeloma (MM) is a type of blood cancer that typically has no cure. Treatments like medications and stem cell ...